Concepedia

D. Tsang

DT

4

Publications

1.6K

Citations

4

H-Index

2015

Active since

Affiliations

University College London(Current)

The Christie NHS Foundation Trust

University of Glasgow

University Hospitals Bristol NHS Foundation Trust

University of Manchester

D. Tsang is an author at University College London specializing in cancer therapeutics, medicine, and oncology.

Top concepts

Publications per year

2015–2020

4

Publications

4

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

John Primrose, Richard Fox, Daniel H. Palmer et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

, , +10

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

Matthew R. Sydes, Melissa Spears, Malcolm D. Mason et al. · Annals of Oncology · 2018 · 240 citations · Full text

Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients – control survival is much better than previously assumed

M. Milošević, John Edwards, D. Tsang et al. · Colorectal Disease · 2020 · 200 citations · Full text

19LBA Docetaxel (Doc) +/− zoledronic acid (ZA) for hormone-naive prostate cancer: First overall survival results from STAMPEDE & treatment effects within subgroups (NCT00268476)

Nicholas D. James, Matthew R. Sydes, M.D. Mason et al. · European Journal of Cancer · 2015 · 14 citations

, , +8

Rows per page

1–4 of 4